Helison Rafael P Carmo, Marcos Y Yoshinaga, Alejandro Rosell Castillo, Adriano Britto Chaves-Filho, Isabella Bonilha, Joaquim Barreto, Stéfanie Primon Muraro, Gabriela Fabiano de Souza, Gustavo Gastão Davanzo, Maurício W Perroud, Kishal Lukhna, Mpiko Ntsekhe, Sean Davidson, Licio A Velloso, Wilson Nadruz, Luiz Sérgio F Carvalho, Miguel Sáinz-Jaspeado, Alessandro S Farias, José Luiz Proença-Módena, Pedro M Moraes-Vieira, Sotirios K Karathanasis, Derek Yellon, Sayuri Miyamoto, Alan T Remaley, Andrei C Sposito
BACKGROUND AND AIMS: Low-density lipoprotein (LDL) plasma concentration decline is a biomarker for acute inflammatory diseases, including coronavirus disease-2019 (COVID-19). Phenotypic changes in LDL during COVID-19 may be equally related to adverse clinical outcomes. METHODS: Individuals hospitalized due to COVID-19 (n = 40) were enrolled. Blood samples were collected on days 0, 2, 4, 6, and 30 (D0, D2, D4, D6, and D30). Oxidized LDL (ox-LDL), and lipoprotein-associated phospholipase A2 (Lp-PLA2) activity were measured...
February 27, 2023: Molecular Genetics and Metabolism